168 related articles for article (PubMed ID: 37612681)
1. Association of hyperhomocysteinemia and chronic kidney disease in the general population: a systematic review and meta-analysis.
Chen W; Feng J; Ji P; Liu Y; Wan H; Zhang J
BMC Nephrol; 2023 Aug; 24(1):247. PubMed ID: 37612681
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population.
Liu PT; Chen JD
Medicine (Baltimore); 2021 Sep; 100(37):e27202. PubMed ID: 34664851
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study.
Shen Z; Zhang Z; Zhao W
BMC Nephrol; 2022 Dec; 23(1):419. PubMed ID: 36587192
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort.
Kong X; Ma X; Zhang C; Su H; Xu D
Int Urol Nephrol; 2017 Apr; 49(4):661-667. PubMed ID: 27822673
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine levels and risk of essential hypertension: A meta-analysis of published epidemiological studies.
Zhong F; Zhuang L; Wang Y; Ma Y
Clin Exp Hypertens; 2017; 39(2):160-167. PubMed ID: 28287885
[TBL] [Abstract][Full Text] [Related]
8. Association of homocysteine level with risk of stroke: A dose-response meta-analysis of prospective cohort studies.
Wu X; Zhou Q; Chen Q; Li Q; Guo C; Tian G; Qie R; Han M; Huang S; Li Y; Yang X; Zhao Y; Feng Y; Liu D; Qin P; Hu D; Zhang M
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1861-1869. PubMed ID: 32912796
[TBL] [Abstract][Full Text] [Related]
9. Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population.
Chao MC; Hu SL; Hsu HS; Davidson LE; Lin CH; Li CI; Liu CS; Li TC; Lin CC; Lin WY
J Nephrol; 2014 Jun; 27(3):299-305. PubMed ID: 24430766
[TBL] [Abstract][Full Text] [Related]
10. Obesity, hyperhomocysteinaemia and risk of chronic kidney disease: a population-based study.
Lai SH; Tsai YW; Chen YC; Chang SS
Fam Pract; 2018 May; 35(3):259-265. PubMed ID: 29092063
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
Ye Z; Zhang Q; Li Y; Wang C; Zhang J; Ma X; Peng H; Lou T
Nutrients; 2016 Oct; 8(10):. PubMed ID: 27775590
[TBL] [Abstract][Full Text] [Related]
12. Association between hyperhomocysteinemia and stroke with atherosclerosis and small artery occlusion depends on homocysteine metabolism-related vitamin levels in Chinese patients with normal renal function.
Wu GH; Kong FZ; Dong XF; Wu DF; Guo QZ; Shen AR; Cheng QZ; Luo WF
Metab Brain Dis; 2017 Jun; 32(3):859-865. PubMed ID: 28261756
[TBL] [Abstract][Full Text] [Related]
13. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum homocysteine and other parameters in renal transplant patients.
Nouri-Majalan N; Masoumi R; Nafisi R; Nogh H; Ghafari A; Moghaddasi S
Transplant Proc; 2009 Sep; 41(7):2826-8. PubMed ID: 19765447
[TBL] [Abstract][Full Text] [Related]
15. Elevated homocysteine and differential risks of the renal function decline in hypertensive patients.
Liu C; Lin L; Xu R
Clin Exp Hypertens; 2020 Aug; 42(6):565-570. PubMed ID: 32174191
[TBL] [Abstract][Full Text] [Related]
16. Serum concentration of homocysteine in spontaneous feline chronic kidney disease.
Giraldi M; Paltrinieri S; Curcio C; Scarpa P
Vet J; 2019 Dec; 254():105358. PubMed ID: 31836166
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.
Kelly PJ; Rosand J; Kistler JP; Shih VE; Silveira S; Plomaritoglou A; Furie KL
Neurology; 2002 Aug; 59(4):529-36. PubMed ID: 12196644
[TBL] [Abstract][Full Text] [Related]
19. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies.
Mozaffari H; Ajabshir S; Alizadeh S
Clin Nutr; 2020 Jul; 39(7):2035-2044. PubMed ID: 31669002
[TBL] [Abstract][Full Text] [Related]
20. Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis.
Lei X; Zeng G; Zhang Y; Li Q; Zhang J; Bai Z; Yang K
Diabetol Metab Syndr; 2018; 10():61. PubMed ID: 30083252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
